CN Stock MarketDetailed Quotes

600267 Zhejiang Hisun Pharmaceutical

Watchlist
  • 7.64
  • +0.10+1.33%
Not Open Apr 26 15:00 CST
9.23BMarket Cap15.01P/E (TTM)

Zhejiang Hisun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Hisun Pharmaceutical Earnings Date

Currency: CNY

Period

Q3 FY2023 Earnings

Oct 28, 2023

Revenue(YoY)

2.64B

-12.18%
Net Income(YoY)

41.81M

+121.42%
Analyst Rating

Strong Buy

Apr 28, 2024

Zhejiang Hisun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/FY-- / 13.268B--
--2023/FY-- / 12.647B--
DatePeriodRevenue/EstimateEarnings Call
--2024/FY-- / 13.268B--
--2023/FY-- / 12.647B--

Zhejiang Hisun Pharmaceutical Earnings Reports

  • Zhejiang Haizheng Pharmaceutical Co., Ltd. 2023 Annual Results Pre-loss Announcement

    Jan 30 11:00 ET

  • Zhejiang Haizheng Pharmaceutical Co., Ltd. 2023 Third Quarter Report

    Oct 27, 2023 12:00 ET

  • Zhejiang Haizheng Pharmaceutical Co., Ltd. Semi-Annual Report 2023

    Aug 21, 2023 12:00 ET

  • Summary of the 2023 semi-annual report of Zhejiang Haizheng Pharmaceutical Co., Ltd.

    Aug 21, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg